Multimodal combination regimen for a patient with advanced huge hepatocellular carcinoma: a case report.

ABSTRACT:

Background

Hepatocellular carcinoma (HCC) is a highly malignant tumor of the digestive system with a poor prognosis. Huge HCC, a subtype characterized by tumors measuring at least 10 cm in diameter, often presents with macrovascular invasion, satellite nodules, metastases, and other aggressive characteristics, posing significant challenges for treatment. The era of combined targeted therapy and immunotherapy has brought new hope to patients with advanced HCC. The development of innovative combination medication regimens for HCC is a current area of intense clinical research interest. We are trying to explore new combination therapies based on target-immunity combination therapy in the hope of better-benefiting patients with advanced huge HCC.

Case description

We present a pa

SUBMITTER: Li S 

PROVIDER: S-EPMC11811550 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature